Intravenous liposomal vaccine enhances CTL generation, but not until antigen presentation
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intravenous liposomal vaccine enhances CTL generation, but not until antigen presentation
Authors
Keywords
Cancer immunotherapy, Liposome, Adjuvant, Liver, Spleen, Immune checkpoint inhibitor
Journal
JOURNAL OF CONTROLLED RELEASE
Volume 343, Issue -, Pages 1-12
Publisher
Elsevier BV
Online
2022-01-20
DOI
10.1016/j.jconrel.2022.01.020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Delivery of toll-like receptor 3 ligand poly(I:C) to the liver by calcium phosphate nanoparticles conjugated with an F4/80 antibody exerts an anti-hepatitis B virus effect in a mouse model
- (2021) Yanqin Du et al. Acta Biomaterialia
- STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation
- (2021) Takashi Nakamura et al. Journal for ImmunoTherapy of Cancer
- Distribution of BCG-CWS loaded nanoparticles in the spleen after intravenous injection affects cytotoxic T lymphocyte activity
- (2020) Hideyuki Masuda et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Poly-ICLC, a multi-functional immune modulator for treating cancer
- (2020) Hussein Sultan et al. SEMINARS IN IMMUNOLOGY
- Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltration
- (2020) Hussein Sultan et al. Journal for ImmunoTherapy of Cancer
- Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1−CD8+ Tumor-Infiltrating T Cells
- (2019) Sema Kurtulus et al. IMMUNITY
- Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy
- (2019) Imran Siddiqui et al. IMMUNITY
- CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer
- (2019) Laura M. McLane et al. Annual Review of Immunology
- A Toll-like receptor 3 (TLR3) agonist ARNAX for therapeutic immunotherapy
- (2019) Tsukasa Seya et al. ADVANCED DRUG DELIVERY REVIEWS
- Advances in cancer immunotherapy 2019 – latest trends
- (2019) Stephan Kruger et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The silencing of indoleamine 2,3-dioxygenase 1 (IDO1) in dendritic cells by siRNA-loaded lipid nanoparticles enhances cell-based cancer immunotherapy
- (2019) Rikito Endo et al. Scientific Reports
- An intra-tumoral niche maintains and differentiates stem-like CD8 T cells
- (2019) Caroline S. Jansen et al. NATURE
- Mechanisms of resistance to immune checkpoint inhibitors
- (2018) Russell W Jenkins et al. BRITISH JOURNAL OF CANCER
- A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade
- (2018) Daniela S. Thommen et al. NATURE MEDICINE
- High-dimensional single cell analysis identifies stem-like cytotoxic CD8+T cells infiltrating human tumors
- (2018) Jolanda Brummelman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma
- (2018) Hanjie Li et al. CELL
- Application of BCG-CWS as a Systemic Adjuvant by Using Nanoparticulation Technology
- (2018) Hideyuki Masuda et al. MOLECULAR PHARMACEUTICS
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Mechanism of splenic cell death and host mortality in a Plasmodium yoelii malaria model
- (2017) Norinne Lacerda-Queiroz et al. Scientific Reports
- The light and the dark sides of Interleukin-10 in immune-mediated diseases and cancer.
- (2016) Jens Geginat et al. CYTOKINE & GROWTH FACTOR REVIEWS
- In Vivo Inverse Correlation in the Activation of Natural Killer T Cells Through Dual-Signal Stimulation via a Combination of α-Galactosylceramide–Loaded Liposomes and Interleukin-12
- (2016) Heba Abdelmegeed et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- Innate Immune Pattern Recognition: A Cell Biological Perspective
- (2015) Sky W. Brubaker et al. Annual Review of Immunology
- Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth
- (2015) Sonja Kleffel et al. CELL
- Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
- (2015) Lieping Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Liposomes loaded with a STING pathway ligand, cyclic di-GMP, enhance cancer immunotherapy against metastatic melanoma
- (2015) Takashi Nakamura et al. JOURNAL OF CONTROLLED RELEASE
- Defined TLR3-specific adjuvant that induces NK and CTL activation without significant cytokine production in vivo
- (2015) Misako Matsumoto et al. Nature Communications
- Combinatorial Immunotherapy of Polyinosinic–Polycytidylic Acid and Blockade of Programmed Death-Ligand 1 Induce Effective CD8 T-cell Responses against Established Tumors
- (2014) Toshihiro Nagato et al. CLINICAL CANCER RESEARCH
- Octaarginine-Modified Liposomes Enhance Cross-Presentation by Promoting the C-Terminal Trimming of Antigen Peptide
- (2014) Takashi Nakamura et al. MOLECULAR PHARMACEUTICS
- Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant
- (2013) Annina M. Hafner et al. ADVANCED DRUG DELIVERY REVIEWS
- The Spleen in Local and Systemic Regulation of Immunity
- (2013) Vincenzo Bronte et al. IMMUNITY
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- The nanoparticulation by octaarginine-modified liposome improves α-galactosylceramide-mediated antitumor therapy via systemic administration
- (2013) Takashi Nakamura et al. JOURNAL OF CONTROLLED RELEASE
- Immunogenicity of Murine Solid Tumor Models as a Defining Feature of In Vivo Behavior and Response to Immunotherapy
- (2013) Melissa G. Lechner et al. JOURNAL OF IMMUNOTHERAPY
- Incorporation of polyinosine–polycytidylic acid enhances cytotoxic T cell activity and antitumor effects by octaarginine-modified liposomes encapsulating antigen, but not by octaarginine-modified antigen complex
- (2012) Takashi Nakamura et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA
- (2011) Federico Perche et al. Nanomedicine-Nanotechnology Biology and Medicine
- Biology of interleukin-10
- (2010) Robert Sabat et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Use of defined TLR ligands as adjuvants within human vaccines
- (2010) Malcolm S. Duthie et al. IMMUNOLOGICAL REVIEWS
- Immunity by formulation design: Induction of high CD8+ T-cell responses by poly(I:C) incorporated into the CAF01 adjuvant via a double emulsion method
- (2010) Pernille Nordly et al. JOURNAL OF CONTROLLED RELEASE
- Blood Cytokines as Biomarkers of In Vivo Toxicity in Preclinical Safety Assessment: Considerations for Their Use
- (2010) Jacqueline M. Tarrant TOXICOLOGICAL SCIENCES
- The Liver as a Lymphoid Organ
- (2009) Ian Nicholas Crispe Annual Review of Immunology
- TLR3: Interferon induction by double-stranded RNA including poly(I:C)☆
- (2008) M MATSUMOTO et al. ADVANCED DRUG DELIVERY REVIEWS
- Mechanism of T cell tolerance induction by murine hepatic Kupffer cells
- (2008) Qiang You et al. HEPATOLOGY
- Efficient MHC Class I Presentation by Controlled Intracellular Trafficking of Antigens in Octaarginine-modified Liposomes
- (2008) Takashi Nakamura et al. MOLECULAR THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started